[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach

PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor outcome and limited therapeutic options. Imaging of IPF is limited to high-resolution computed tomography (HRCT) which is often not sufficient for a definite diagnosis and has a limited impact on therapeutic decision and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanguy, Julie, Goirand, Françoise, Bouchard, Alexanne, Frenay, Jame, Moreau, Mathieu, Mothes, Céline, Oudot, Alexandra, Helbling, Alex, Guillemin, Mélanie, Bonniaud, Philippe, Cochet, Alexandre, Collin, Bertrand, Bellaye, Pierre-Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426306/
https://www.ncbi.nlm.nih.gov/pubmed/33580818
http://dx.doi.org/10.1007/s00259-021-05209-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426306/
https://www.ncbi.nlm.nih.gov/pubmed/33580818
http://dx.doi.org/10.1007/s00259-021-05209-2

Ejemplares similares